Practical Steps for Starting Semaglutide Postpartum with PlexusDx Begin by scheduling a consultation with your OB-GYN or primary care provider to confirm complete wound healing, normal lochia cessation, and stable nutritional markers (hemoglobin, albumin, vitamin D if available)
The STEP 1 trial demonstrated that participants using a GLP-1 receptor agonist achieved a mean weight loss of approximately 14.9% of their body weight over 68 weeks, which is remarkable by any clinical standard (Wilding et al
Biologic therapies require a greater upfront investment but often need fewer sessions with more lasting benefits
There are many obesity treatment options
In a clinical trial conducted for 68 weeks, people taking Semaglutide 2.4 mg lost a 14.9% change in their body weight
Trusted Brand Transparency Purchasing directly from NEXAPH helps customers avoid counterfeit products commonly found through unofficial sellers